{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:57:41Z","timestamp":1781323061793,"version":"3.54.1"},"reference-count":14,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":162,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Hematology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"\n Background<\/jats:title>\n Chronic myelomonocytic leukemia (CMML) is a clonal myelodysplastic\/myeloproliferative neoplasm characterized by persistent peripheral blood monocytosis and dysplastic bone marrow morphology. Multiple myeloma (MM) is a plasma cell malignancy defined by clonal plasma cell proliferation and myeloma\u2010defining events. The synchronous occurrence of CMML and MM is exceptionally rare, particularly in treatment\u2010na\u00efve and relatively young patients.<\/jats:p>\n <\/jats:sec>\n \n Case Presentation<\/jats:title>\n \n We present a 42\u2010year\u2010old\u2010male presenting with progressive fatigue and leukocytosis. Laboratory evaluation revealed marked absolute monocytosis (16.4\u2009\u00d7\u200910\n 9<\/jats:sup>\n \/L), anemia, and neutropenia. Bone marrow examination demonstrated an expanded abnormal monocytic population, further confirmed by multiparametric flow cytometry. Conventional cytogenetic analysis revealed monosomy 7, supporting the presence of a clonal myeloid neoplasm consistent with CMML. Concurrently, bone marrow biopsy showed 10%\u201315% plasma cells. Serum protein electrophoresis identified an IgG kappa monoclonal paraprotein (3.5\u2009g\/dL), and imaging showed a lytic bone lesion and biopsy\u2010provided extramedullary plasmacytoma, meeting the diagnostic criteria of symptomatic MM. The patient has no prior exposure to cytotoxic therapy. He received one cycle of azacitidine with subsequent worsening cytopenias, underscoring therapeutic complexity.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This case describes a rare concurrent presentation of CMML and MM in a young, treatment\u2010na\u00efve patient. The combination of persistent monocytosis, dysplastic marrow findings, and monosomy 7 supported the presence of clonal myeloid process coexisting with plasma cell myeloma. Recognizing concurrent hematologic malignancies is essential, as diagnostic overlap and treatment interactions present substantial management challenges. Additional molecular characterization of similar cases may elucidate potential pathogenetic connections and guide tailored therapeutic approaches.<\/jats:p>\n <\/jats:sec>","DOI":"10.1155\/crh\/5531249","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:43:14Z","timestamp":1781322194000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synchronous Presentation of Chronic Myelomonocytic Leukemia and Multiple Myeloma in a Treatment\u2010Na\u00efve Patient"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7130-156X","authenticated-orcid":false,"given":"Moutaz W.","family":"Sweileh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Qamhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Batta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Asaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan Yousef","family":"Odeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoun","family":"Swaileh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"e_1_2_14_1_2","volume-title":"WHO Classification of Tumours: Haematolymphoid Tumours","author":"Board W. C. T. E.","year":"2022"},{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27271"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.11.004"},{"key":"e_1_2_14_4_2","volume-title":"WHO Classification of Tumours: Haematolymphoid Tumours 2022","author":"Board W. C. T. E.","year":"2022"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1991.tb00457.x"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840101)53:1<83::aid-cncr2820530115>3.0.co;2-q"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17505"},{"key":"e_1_2_14_8_2","first-page":"263","article-title":"Chronic Myelomonocytic Leukemia Following Prolonged Alkylating Agent Therapy for Multiple Myeloma","volume":"60","author":"Natazuka T.","year":"1994","journal-title":"International Journal of Hematology"},{"key":"e_1_2_14_9_2","first-page":"157","article-title":"Three Cases of Multiple Myeloma Developing Into Melphalan-Related Chronic Myelomonocytic Leukemia","volume":"22","author":"Ueki K.","year":"1991","journal-title":"Journal of Medicine"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279500"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70075"},{"key":"e_1_2_14_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.112"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-631747"}],"container-title":["Case Reports in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crh\/5531249","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/crh\/5531249","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crh\/5531249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:43:16Z","timestamp":1781322196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/crh\/5531249"}},"subtitle":[],"editor":[{"given":"Kalyani","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/crh\/5531249"],"URL":"https:\/\/doi.org\/10.1155\/crh\/5531249","archive":["Portico"],"relation":{},"ISSN":["2090-6560","2090-6579"],"issn-type":[{"value":"2090-6560","type":"print"},{"value":"2090-6579","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2026-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"5531249"}}